IMNM
Immunome, Inc.
Stock
$20.90+0.01 (+0.05%)Close Oct 2, 2026
- Operating income, 2025
- −$224M
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | −$224M | — |
| 2024 | −$306M | — |
| 2023 | −$110M | — |
| 2022 | −$37M | — |
| 2021 | −$25M | — |
| 2020 | −$12M | — |
| 2019 | −$10M | — |